×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Oncostream member and receive full access to its content!
You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.
Registration Login
Registration Login
Modératrice :
Pr Isabelle Ray-Coquard
Orateurs :
Dr Maria Selloua
Dr Olivia Le Saux
Dr Coriolan Lebreton
| 13:00 |
Introduction |
| 13:05 |
Cas clinique #1 : Carcinosarcome débutant, en récidive précoce après CR adjuvante Carbo Taxol, Maria Selloua - Rappel possibilité inclusion essai RAINBO, Colorian Lebreton - Quelle proposition thérapeutique (ROCSAN) |
| 13:20 |
Cas clinique #2 : K endomètre NSMP M+ d'emblée. Récidive <12 mois après Carbo Taxol et IO - Quelles options thérapeutiques, Olivia Le Saux |
| 13:35 |
Débat/Discussion et réponses aux questions Olivia Le Saux, Coriolan Lebreton & Isabelle Ray-Coquard |
Ne manquez pas les prochaines sessions sur la prise en charge du cancer de l'endomètre avancé !
| Épisode 3 |
Cancer de l'endomètre avancé pMMR P53 muté RDV le 9 avril 2025 13h |
| Épisode 4 |
Cancer de l'endomètre avancé pMMR NSMP RDV le 29 avril 2025 13h |
Shooting date : 2025-03-26
Last update : 2025-04-04
Last update : 2025-04-04
Suggestions
Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Honolulu : Wednesday, May 18th 2022 from 06:30am to 08am (GMT+2)
San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)
San Francisco : Wednesday, May 18th 2022 from 09:30am to 11am (GMT+2)
New York : Wednesday, May 18th 2022 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Wednesday, May 18th 2022 from 01:30pm to 03pm (GMT+2)
Reykjavik : Wednesday, May 18th 2022 from 04:30pm to 06pm (GMT+2)
London / Dublin : Wednesday, May 18th 2022 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, May 18th 2022 from 06:30pm to 08pm (GMT+2)
Istanbul : Wednesday, May 18th 2022 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, May 18th 2022 from 08:30pm to 10pm (GMT+2)
Bangkok : Wednesday, May 18th 2022 from 11:30pm to 01am (GMT+2)
Shanghai : Thursday, May 19th 2022 from 12:30am to 02am (GMT+2)
Tokyo : Thursday, May 19th 2022 from 01:30am to 03am (GMT+2)
Sydney : Thursday, May 19th 2022 from 03:30am to 05am (GMT+2)
Wellington : Thursday, May 19th 2022 from 05:30am to 07am (GMT+2)
Importance de la chimio-sensibilité dans la prise en charge des cancers de l’ovaire
Share
Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT+1)
San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)
San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT+1)
New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT+1)
Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT+1)
London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+1)
Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+1)
Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+1)
Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+1)
Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+1)
Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+1)
Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022
Share
Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+1)
San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+1)
Cancer de l'ovaire en 1L :
Actualités et options thérapeutiques disponibles en 2023
Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)
Toxicités hématologiques des inhibiteurs de PARP
Regards croisés oncologue-hématologue-interniste
Share